文献速递心境障碍会诊联络精神医学

甲状腺功能减退与临床抑郁的关联:系统综述与荟萃分析

Association of Hypothyroidism and Clinical Depression: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Psychiatry · 2021-01-01

该系统综述与荟萃分析纳入25项研究、348 014名参与者,发现甲状腺功能减退与临床抑郁存在关联(OR 1.30,95%CI 1.08-1.57)。亚组分析显示该关联在显性甲状腺功能减退(OR 1.77)中强于亚临床甲状腺功能减退(OR 1.13),事后分析中仅在女性个体中确认关联(OR 1.48)。

要点

  • 甲状腺功能减退与临床抑郁的关联强度低于既往假设(OR 1.30)。
  • 显性甲减的关联(OR 1.77)强于亚临床甲减(OR 1.13)。
  • 关联仅在女性中确认(OR 1.48),男性中不显著(OR 0.71)。

核心结论

  • 甲状腺功能减退与临床抑郁的关联效应量远低于既往假设。
  • 该关联可能仅限于显性甲状腺功能减退和女性个体。
  • 自身免疫单独可能不是该共病的驱动因素。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、PsycINFO和Embase数据库自建库至2020年5月。
  • 纳入25项流行病学或人群研究,共348 014名参与者。
  • 两名评审独立筛选研究、提取数据并基于纽卡斯尔-渥太华量表评估质量。
  • 采用随机效应荟萃分析计算汇总比值比(OR)。

主要发现

  • 甲状腺功能减退与临床抑郁的关联OR为1.30(95%CI 1.08-1.57)。
  • 自身免疫与临床抑郁的关联OR为1.24(95%CI 0.89-1.74),结果不确定。
  • 显性甲状腺功能减退的OR为1.77(95%CI 1.13-2.77),亚临床甲状腺功能减退的OR为1.13(95%CI 1.01-1.28)。
  • 事后分析中,女性个体关联OR为1.48(95%CI 1.18-1.85),男性个体OR为0.71(95%CI 0.40-1.25)。
  • 敏感性分析得到更保守的估计。

临床怎么用

  • 在临床抑郁患者中应考虑评估甲状腺功能,尤其是女性。
  • 显性甲状腺功能减退与抑郁的关联更强,亚临床甲减的关联较弱。
  • 自身免疫单独可能不足以解释甲状腺功能减退与抑郁的共病。

局限性

  • 敏感性分析结果更为保守,提示关联估计可能不稳定。
  • 自身免疫与临床抑郁的关联结果不确定(95%CI含1)。
  • 男性个体关联不显著,可能受样本量限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Hypothyroidism is considered a cause of or a strong risk factor for depression, but recent studies provide conflicting evidence regarding the existence and the extent of the association. It is also unclear whether the link is largely due to subsyndromal depression or holds true for clinical depression. OBJECTIVE: To estimate the association of hypothyroidism and clinical depression in the general population. DATA SOURCES: PubMed, PsycINFO, and Embase databases were searched from inception until May 2020 for studies on the association of hypothyroidism and clinical depression. STUDY SELECTION: Two reviewers independently selected epidemiologic and population-based studies that provided laboratory or International Statistical Classification of Diseases and Related Health Problems diagnoses of hypothyroidism and diagnoses of depression according to operationalized criteria (eg, Diagnostic and Statistical Manual of Mental Disorders or International Statistical Classification of Diseases and Related Health Problems) or cutoffs in established rating scales. DATA EXTRACTION AND SYNTHESIS: Two reviewers independently extracted data and evaluated studies based on the Newcastle-Ottawa Scale. Summary odds ratios (OR) were calculated in random-effects meta-analyses. MAIN OUTCOMES AND MEASURES: Prespecified coprimary outcomes were the association of clinical depression with either hypothyroidism or autoimmunity. RESULTS: Of 4350 articles screened, 25 studies were selected for meta-analysis, including 348 014 participants. Hypothyroidism and clinical depression were associated (OR, 1.30 [95% CI, 1.08-1.57]), while the OR for autoimmunity was inconclusive (1.24 [95% CI, 0.89-1.74]). Subgroup analyses revealed a stronger association with overt than with subclinical hypothyroidism, with ORs of 1.77 (95% CI, 1.13-2.77) and 1.13 (95% CI, 1.01-1.28), respectively. Sensitivity analyses resulted in more conservative estimates. In a post hoc analysis, the association was confirmed in female individuals (OR, 1.48 [95% CI, 1.18-1.85]) but not in male individuals (OR, 0.71 [95% CI, 0.40-1.25]). CONCLUSIONS AND RELEVANCE: In this systematic review and meta-analysis, the effect size for the association between hypothyroidism and clinical depression was considerably lower than previously assumed, and the modest association was possibly restricted to overt hypothyroidism and female individuals. Autoimmunity alone may not be the driving factor in this comorbidity.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Bode H, Ivens B, Bschor T, et al. Association of Hypothyroidism and Clinical Depression: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2021. PMID: 34524390. doi:10.1001/jamapsychiatry.2021.2506

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。